Specific Interventions - Pharmacologic

Saturday, May 17, 2014: 11:30 AM-1:30 PM
Atrium Ballroom (Marriott Marquis Atlanta)
11:30 AM
177.140
140 Patterns of Psychotropic Medication Use Among Children Referred for Autism Spectrum Disorder Evaluation
I. Bukelis, F. J. Biasini, K. C. Guest, S. E. O'Kelley, A. N. Harris and A. Patel
11:30 AM
177.141
141 Modulation of the Locus Coeruleus-Noradrenergic System with Milnacipran Vs Placebo in Autism Spectrum Disorder
R. H. Noone, C. J. Ferretti, B. P. Taylor, E. Racine, J. L. Kirsch and E. Hollander
11:30 AM
177.142
142 Multi-Site Randomised Controlled Trial of Fluoxetine in Children and Adolescents with Autism (FAB): Rationale and Design
A. Mouti, M. Kohn, D. Reddihough, C. Marraffa, P. Hazell, J. Wray, K. Lee, P. J. Santosh, S. Reid, D. Dossetor, N. Silove, J. Carlin, A. Whitehouse, J. Granich, S. Kloprogge, M. O'Sullivan, F. Orsini, P. Lockhart, S. Clarke and A. Poulton
11:30 AM
177.143
143 Preliminary Investigation of Lithium for Mood Disorder Symptoms in Children with Autism Spectrum Disorder
M. Siegel, C. A. Beresford, O. Teer, M. Bunker, M. Verdi, A. Stedman and K. A. Smith
See more of: Specific Interventions - Pharmacologic
<< Previous Session | Next Session >>

Quick Links

Connect

Public Relations

Media Registration

INSAR | 342 North Main Street West Hartford, CT 06117-2507 USA © 2012 INSAR | International Society for Autism Research